Skip to main content
. Author manuscript; available in PMC: 2012 Oct 8.
Published in final edited form as: J Thorac Oncol. 2012 May;7(5):825–832. doi: 10.1097/JTO.0b013e318247504a

FIGURE 3.

FIGURE 3

Kaplan-Meier estimates of overall survival (A, C) and disease-free survival (B, D) based on pathologic stages (A, B) and percentage of viable tumor cells (C, D). A, The overall survival was significantly longer in patients with stages 0, IA, and IB than in patients with pathologic stage II, III, or IV. B, The disease-free survival was significantly longer in patients with stages 0, IA, and IB than in patients with pathologic stage II, III, or IV. C, The overall survival was significantly longer in patients with ≤10% viable tumor cells than in patients with >10% viable tumor cells. D, The disease-free survival was significantly longer in patients with ≤10% viable tumor cells than in patients with >10% viable tumor cells.